These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19002797)

  • 1. Transcriptional regulation of MDR genes.
    Scotto KW; Egan DA
    Cytotechnology; 1998 Sep; 27(1-3):257-69. PubMed ID: 19002797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
    Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.
    Center MS
    Cytotechnology; 1993; 12(1-3):109-25. PubMed ID: 7765322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of P-glycoprotein genes in primary rat hepatocytes by collagen sandwich and drugs.
    Lee CH
    J Cell Biochem; 2002; 86(1):12-20. PubMed ID: 12112011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.
    Al-Akra L; Bae DH; Sahni S; Huang MLH; Park KC; Lane DJR; Jansson PJ; Richardson DR
    J Biol Chem; 2018 Mar; 293(10):3562-3587. PubMed ID: 29305422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics.
    Seebacher NA; Richardson DR; Jansson PJ
    Br J Pharmacol; 2015 May; 172(10):2557-72. PubMed ID: 25586174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of multidrug resistance in leukemia cells during chemotherapy: mechanisms and prevention.
    Shtil AA
    J Hematother Stem Cell Res; 2002 Apr; 11(2):231-41. PubMed ID: 11983096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
    Chaudhary PM; Roninson IB
    J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.
    Mickley LA; Bates SE; Richert ND; Currier S; Tanaka S; Foss F; Rosen N; Fojo AT
    J Biol Chem; 1989 Oct; 264(30):18031-40. PubMed ID: 2572588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
    Krishna R; Mayer LD
    Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo.
    Yang X; Feng Y; Gao Y; Shen J; Choy E; Cote G; Harmon D; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    Gynecol Oncol; 2015 Apr; 137(1):134-42. PubMed ID: 25677062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.
    Yang X; Yang P; Shen J; Osaka E; Choy E; Cote G; Harmon D; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    Br J Cancer; 2014 Jun; 110(12):2896-904. PubMed ID: 24853187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review).
    Tian Y; Lei Y; Wang Y; Lai J; Wang J; Xia F
    Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37654171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas.
    Bates SE; Shieh CY; Mickley LA; Dichek HL; Gazdar A; Loriaux DL; Fojo AT
    J Clin Endocrinol Metab; 1991 Jul; 73(1):18-29. PubMed ID: 1675220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.
    Kopecka J; Campia I; Jacobs A; Frei AP; Ghigo D; Wollscheid B; Riganti C
    Oncotarget; 2015 Mar; 6(9):6776-93. PubMed ID: 25686827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.